+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Combination Drug Delivery Approach as an Effective Therapy for Various Diseases

  • Book

  • April 2022
  • Elsevier Science and Technology
  • ID: 5458216

Combination Drug Delivery Approach as an Effective Therapy for Various Diseases explores the use of bioengineering tools in combination drug delivery approaches to control various diseases at different clinical stages of synergistic action, varying mechanisms of action, and during the suppression of drug resistance. The book presents fundamental knowledge on the experiential and experimental aspects of drug combination approaches in order to equip rational applications in preventing the emergence of resistance during the treatment of various diseases. It provides a holistic understanding of the principles behind formation, characterization, applications, regulations, toxicity, challenges and future perspectives of combination drug delivery approaches.

It will be of interest to researchers and advanced graduate students in pharmaceutical science, chemistry, biology and medicine, as well as pharmaceutical companies and scientific organizations.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Section 1: Combination drug delivery approaches against various diseases 1. Drug resistance as challenges to effective therapy 2. Overcoming the challenges of drug resistance through combination drug delivery approach 3. Combination drug delivery approaches for pulmonary diseases 4. Combination drug delivery approaches in ophthalmology 5. Combination drug delivery system to enhance the transdermal drug delivery 6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis 7. Combination drug delivery approaches for cardiovascular disease 8. Combination drug delivery approaches for viral infection 9. Combination drug delivery approaches for malaria parasite 10. Combination drug delivery approaches for tuberculosis

Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment

Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and�postmarket�regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems

Authors

Prashant Kesharwani Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.

Dr. Prashant Kesharwani is presently working as an assistant professor at Department of Pharmaceutics, Jamia Hamdard, New Delhi, India. He is also a receipt of several prestigious international and national awards such as "USERN Laureate 2023� and "SERB-Ramanujan fellowship�. Dr. Kesharwani have academic, industrial and research experience at international level (including USA, Malaysia and India). An overarching goal of his current research is the development of nano-engineered drug delivery systems for various diseases. Dr. Kesharwani has more than 300 international publications in well reputed journals and 23 published international books. His h-index is 76 and i-10 index is 305 (on May 2024). He is a recipient of several internationally acclaimed awards and research funding from various funding bodies. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of wider community.